View Archive

Entries for January 2003

Vinyl Chloride: The Overview of the Conspiracy (Ross v. Conoco)

In this statement, plaintiffs identify, chronologically, the date and location each defendant joined the conspiracy largely through the acts of each defendant’s representative(s) on the various vinyl chloride-related committees identified herein. 

Vinyl Chloride Plants in New Jersey

Plants that made vinyl chloride monomer and other products.

Vinyl Chloride Related Diseases

There are many adverse health effects that can occur in persons who have been exposed to vinyl chloride, including angiosarcoma, liver cancer and disease, brain cancer, Raynaud's syndrome, and acro-osteolysis. The following list describes each of these ailments.

US Supreme Court declines to become involved in the automakers attempt to consolidate cases in federal bankruptcy court.

GM, Ford & DaimlerChrysler lost in their attempt to transfer State court cases and Federal cases into the Federal-Mongul Corp. bankruptcy action. 

Who Is Exposed to Asbestos - Who is At Risk?
 Many occupations and lifestyles have a history of exposure to high levels of asbestos fiber. If you have engaged in one or more of the following...
Beryllium Disease: Who is at Risk?

Workers, Family Members & Household Contacts and Bystanders 

The Asbestos Companies Try to Cook the Books to Avoid Payments

Asbestos, "The Miracle Mineral", was always advertised as indestructible. The intractable legacy that it has left upon the judicial system is like the mineral's everlasting physical properties and the incurable diseases that it causes. Late September 2002, only weeks before the close of the 107th Congress, Senator Patrick Leahy (D-VT.), then Chairman of the Senate Judiciary Committee, held congressional hearings concerning the status of asbestos litigation in the United States. 

Defense Denied Medical Expert When Latex-Free Environment Not Guaranteed

Pennsylvania: Defense Denied Medical Expert Evaluation When a Latex-Free Environment Cannot be Guaranteed

Enbrel and Remicade Companies Sued for Infections and Deaths

In August one of the first cases was filed against the manufacturer of the biological product, Enbrel (etanercept). Enbrel (etanercept) was approved by the U.S. Food and Drug Administration on November 2, 1998, as a second-line agent for the treatment of juvenile rheumatoid arthritis. At the time Enbrel was co-marketed by Immunex, Corp. 

Warnings Issued for Remicade (Infliximab)used For Rheumatoid Arthritis and Crohn's

Remicade (Infliximab) is an immune-suppressing product manufactured by Centocor, a wholly owned subsidiary of Johnson & Johnson, which has been approved by the U.S. Food and Drug Administration for the use for Crohn's disease and rheumatoid arthritis. Remicade is a worldwide market share leader among tumor necrosis factor alpha therapies and is the only biologic drug indicated for the treatment of both Rheumatoid Arthritis and Crohns' disease.

Temporary Disability--When out of work and under authorized medical care for more than 7 days (retroactive), you are entitled to receive temporary disability benefits not to exceed 70% of the State Average Weekly Wage (SAWW).

Copyright 2021 by Jon Gelman, LLC - Attorney at Law. All rights reserved.   |  Privacy Statement  |  Terms Of Use